Arylpiperazine Derivatives and their Use as Selective Dopamine D3 Receptor Ligands
申请人:Capet Marc
公开号:US20080214542A1
公开(公告)日:2008-09-04
The invention concerns compounds of general formula (I), a method for preparing same, as well as their use as therapeutic agent.
这项发明涉及一般式(I)的化合物,以及制备这些化合物的方法,以及它们作为治疗剂的用途。